Zenas BioPharma, Inc.（ZBIO）内部人交易：高管与董事近期交易
过去 18 个月，共有 14 位内部人为 Zenas BioPharma, Inc.（ZBIO）报告了 37 笔 Form 4 交易（最近一笔 2026-06-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-17 | Farmer Joseph L | President and Chief Operating Officer | 买入 | 974 | $13,003 |
| 2026-06-17 | Fox Jennifer A. | Chief Business Officer and Chief Financial Officer | 买入 | 1,592 | $21,253 |
| 2026-05-18 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 60,000 | $1.0M |
| 2026-04-29 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 25,000 | $450,500 |
| 2026-04-29 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 35,000 | $616,700 |
| 2026-04-02 | Lu Hongbo | 董事 | 买入 | 3,768 | $70,198 |
| 2026-04-01 | Harwin Peter Evan | 董事 | 买入 | 150,000 | $3.0M |
| 2026-04-01 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 150,000 | $3.0M |
| 2026-04-01 | Fairmount Funds Management LLC | 董事 | 买入 | 150,000 | $3.0M |
| 2026-04-01 | Kiselak Tomas | 董事 | 买入 | 150,000 | $3.0M |
| 2026-03-31 | Lu Hongbo | 董事 | 买入 | 75,000 | $1.5M |
| 2026-03-31 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 34,000 | $656,540 |
| 2026-03-31 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 20,000 | $364,600 |
| 2026-02-13 | Lu Hongbo | 董事 | 买入 | 25,985 | $584,662 |
| 2026-02-13 | Allen Patricia L | 董事 | 买入 | 5,000 | $118,850 |
| 2026-02-13 | Allen Patricia L | 董事 | 买入 | 5,700 | $138,738 |
| 2026-02-13 | Allen Patricia L | 董事 | 买入 | 5,000 | $132,500 |
| 2026-02-13 | Allen Patricia L | 董事 | 买入 | 4,160 | $109,658 |
| 2026-02-03 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 57,000 | $1.0M |
| 2026-01-09 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 50,000 | $819,000 |
| 2026-01-09 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 30,000 | $489,000 |
| 2026-01-09 | MOULDER LEON O JR | Chief Executive Officer | 买入 | 20,000 | $331,000 |
| 2025-10-14 | ENRIGHT PATRICK G | 董事 | 买入 | 105,265 | $2.0M |
| 2025-10-14 | ENRIGHT PATRICK G | 董事 | 买入 | 11,990 | $249,992 |
| 2025-10-14 | George Simeon | 10% 以上股东 | 买入 | 63,158 | $1.2M |
来源：SEC Form 4 申报文件 · 截至 2026-06-17